Quality Management New Generation Medication Reports

The Texas Department of State Health Services (DSHS) conducts a focused desk review of the New Generation Medication program to ensure compliance with the Performance Contract requirements, to verify accuracy of data in CARE and to support Local Authority quality improvement processes. DSHS Mental Health Quality Management selects a sample of individuals with CARE assignments for New Generation Medication funded by General Revenue. The New Generation Medication review verifies that individuals who received NGM funding have documentation to verify accurate funding source code, diagnosis, name of NGM, physician's medication order for NGM during the review period, and continuation of NGM for consumers discharged from a state facility within the review period. Each Local Mental Health Authority receives a copy of the New Generation Medication focused review report and their individual NGM results.


Last updated September 1, 2010